NET PROFIT (x1000 SEK)
EMPLOYEES
Swedish Orphan Biovitrum A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
8,203
|
6,332
|
5,938 |
| Total assets |
54,319
|
48,104
|
46,371 |
| Current assets |
54,031
|
47,814
|
46,098 |
| Current liabilities |
7,189
|
6,998
|
12,959 |
| Equity capital |
47,130
|
82,212
|
66,826 |
| - share capital |
744
|
748
|
688 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.8%
|
170.9%
|
144.1% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
751.6%
|
683.3%
|
355.7% |
| Return on equity (ROE) |
17.4%
|
7.7%
|
8.9% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.